1. Market Research
  2. > Injury - Pipeline Review, H2 2013

Injury - Pipeline Review, H2 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 37 pages

Injury - Pipeline Review, H2 2013

Summary

Global Markets Direct’s, 'Injury - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Injury. Injury - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Injury.
- A review of the Injury products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Injury pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Injury.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Injury pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table Of Contents

Injury - Pipeline Review, H2 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Injury Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Injury 7
Injury Therapeutics under Development by Companies 9
Injury Therapeutics under Investigation by Universities/Institutes 10
Discovery and Pre-Clinical Stage Products 11
Comparative Analysis 11
Injury Therapeutics - Products under Development by Companies 12
Injury Therapeutics - Products under Investigation by Universities/Institutes 13
Companies Involved in Injury Therapeutics Development 14
Ascent Therapeutics 14
Atox Bio Inc. 15
Cornerstone Therapeutics Inc. 16
Injury - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
HMGB1 Monoclonal Antibody - Drug Profile 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
AB-103 - Drug Profile 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Platelet Receptors Inhibitor - Drug Profile 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
GM1-Targeted Linoleate-Containing TLR2 ligand - Drug Profile 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
ATI-2341 - Drug Profile 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
Human sRAGE Protein - Drug Profile 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
Injury Therapeutics - Drug Profile Updates 31
Injury Therapeutics - Dormant Products 33
Injury - Product Development Milestones 34
Featured News and Press Releases 34
Oct 03, 2012: Oxygen Biotherapeutics Signs Cooperative Research And Development Agreement With US Navy To Investigate Oxycyte For Complex Infected Wounds And Related Injuries 34
Jul 30, 2012: Stem Cell Therapy May Offer New Hope For Defects And Injuries To Head, Mouth 34
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37

List of Tables

Number of Products Under Development for Injury, H2 2013 7
Products under Development for Injury - Comparative Analysis, H2 2013 8
Number of Products under Development by Companies, H2 2013 9
Number of Products under Investigation by Universities/Institutes, H2 2013 10
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 11
Products under Development by Companies, H2 2013 12
Products under Investigation by Universities/Institutes, H2 2013 13
Ascent Therapeutics, H2 2013 14
Atox Bio Inc., H2 2013 15
Cornerstone Therapeutics Inc., H2 2013 16
Assessment by Monotherapy Products, H2 2013 17
Assessment by Stage and Route of Administration, H2 2013 19
Assessment by Stage and Molecule Type, H2 2013 21
Injury Therapeutics - Drug Profile Updates 31
Injury Therapeutics - Dormant Products 33

List of Figures

Number of Products under Development for Injury, H2 2013 7
Products under Development for Injury - Comparative Analysis, H2 2013 8
Products under Development by Companies, H2 2013 9
Products under Investigation by Universities/Institutes, H2 2013 10
Discovery and Pre-Clinical Stage Products, H2 2013 11
Assessment by Monotherapy Products, H2 2013 17
Assessment by Route of Administration, H2 2013 18
Assessment by Stage and Route of Administration, H2 2013 19
Assessment by Molecule Type, H2 2013 20
Assessment by Stage and Molecule Type, H2 2013 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.